Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ifetroban for Portal Hypertension in Cirrhotic Patients
NCT02802228Phase 2Completed
- Sponsor
- Cumberland Pharmaceuticals
- Start
- Mar 2017
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ifetroban in Portal Hypertension (PH), sponsored by Cumberland Pharmaceuticals. Started Mar 2017; status: completed.
02
Drugs
ifetroban
03
Conditions
Portal Hypertension (PH)
Beyond the preview
Go deeper on NCT02802228.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02802228.